PHARMACOR ROXITHROMYCIN roxithromycin 150 mg film coated tablets blister pack

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

roxithromycin, Quantity: 150 mg

から入手可能:

Arrotex Pharmaceuticals Pty Ltd

INN（国際名）:

Roxithromycin

医薬品形態:

Tablet, film coated

構図:

Excipient Ingredients: sodium starch glycollate type A; glucose; sodium starch glycollate type B; maize starch; hypromellose; colloidal anhydrous silica; titanium dioxide; purified talc; povidone; propylene glycol; hyprolose; poloxamer; magnesium stearate

投与経路:

Oral

パッケージ内のユニット:

10 tablets

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Adults: Roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: Upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. Lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. Skin and skin structure infections. Nongonococcal urethritis. Children: ROXITHROMYCIN 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible microorganisms: Acute pharyngitis. Acute tonsillitis, impetigo. Appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. Therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

製品概要:

Visual Identification: White to off-white, round, convex film coated tablets.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Licence status A

承認日:

2008-04-10